Dorsey & Whitney Trust’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
VCM
VPM
Dorsey & Whitney Trust's BIIB Position: Q1 2026 in Review
Dorsey & Whitney Trust increased its Biogen (BIIB) stake by 2.7% in Q1 2026, buying an estimated $7.37K and bringing the position to 1,546 shares worth $283K. The position accounts for 0.02% of the portfolio, ranked #584.
Dorsey & Whitney Trust first reported a position in BIIB in Q2 2013 and has held it in 18 quarters since. The position peaked at $574K in Q1 2015. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.
- Dorsey & Whitney Trust held 1,546 shares of Biogen worth $283K as of Q1 2026.
- Dorsey & Whitney Trust bought 40 Biogen shares in Q1 2026, an estimated $7.37K.
- Biogen made up 0.02% of Dorsey & Whitney Trust's portfolio in Q1 2026, its #584 holding.
- Dorsey & Whitney Trust first reported a position in Biogen in Q2 2013 and has held it in 18 quarters since.
- Dorsey & Whitney Trust's Biogen position peaked at $574K in Q1 2015.
- 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.
Based on Dorsey & Whitney Trust's 13F filing for Q1 2026, filed 14 May 2026.